CoChat

Pharmacotherapy of amphetamine‐type stimulant dependence: An update

Open access
Brensilver, Matthew, Heinzerling, Keith G., Shoptaw, Steven · 2013 · Drug and Alcohol Review
Cited by 124

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Issues.: Methamphetamine‐ or amphetamine‐type stimulants are the second most frequently used illicit drug worldwide, second only to cannabis. Behavioural treatments are efficacious, but their impact is limited underscoring the need for other treatment options, notably, pharmacotherapy. Approach.: A review of randomised controlled trials of pharmacotherapies for methamphetamine‐ or amphetamine‐type stimulants was performed using PubMed and G oogle Scholar databases. Evidence for efficacy of medications is reported. Key Findings.: Clinical trials have yielded no broadly effective pharmacotherapy. Promising signals have been observed for methylphenidate, naltrexone, bupropion and mirtazapine in subgroups of patients in reducing stimulant use (e.g. patients with less severe dependence at baseline and men who have sex with men), though none has produced an unambiguous, replicable signal of efficacy. Implications.: Problems in Phase II trials, including high dropout rates, missing data and a lack of agreement on outcomes, complicate efforts to find a broadly effective pharmacotherapy for amphetamine‐type stimulant disorders. Efforts to address these problems include calls for better validation of pharmacological target exposure, receptor binding and functional modulation. As well, there is a need for agreement in using findings from preclinical and early phases of the medication development process for selecting better pharmacotherapy candidates. Conclusion.: After over 20 years of efforts worldwide to develop a broadly effective medication for dependence on methamphetamine‐ or amphetamine‐type stimulants, no candidate has emerged. This highlights the need for new compounds, consistent and stringent research methods, better integration between preclinical and clinical stages of medication development, and improved collaboration between government, industry and researchers. [Brensilver M, Heinzerling KG, Shoptaw S. Pharmacotherapy of amphetamine‐type stimulant dependence: An update. Drug Alcohol Rev 2013;32:449–460]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dar.12048

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 124

Metadata

Authors
Brensilver, M., Heinzerling, K. G., & Shoptaw, S.
Venue
Drug and Alcohol Review
Publisher
Wiley
Published
2013-04-25
Volume
32
Issue
5
Pages
449-460
ISSN
  • 0959-5236 (ISSN-L)
  • 1465-3362
OpenAlex
W2155613326
Cited by
124
References
24
FWCI
12.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacotherapy of amphetamine‐type stimulant dependence: An update. https://app.cochat.ai/papers/10.1111/dar.12048
The paper
Brensilver, M., Heinzerling, K. G., & Shoptaw, S. (2013). Pharmacotherapy of amphetamine‐type stimulant dependence: An update. Drug and Alcohol Review. https://doi.org/10.1111/dar.12048

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.